CeriBell
CBLL | NASDAQ
$26.42
+$0.28 (+1.07%)
At close: Nov 16, 2026, 4:00 PM ET
$26.42
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
CeriBell Company Profile
Company profile explainedCompany Profile
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Key Executives
| Name | Position |
|---|---|
| Xingjuan Chao | Co-Founder, President, Chief Executive Officer & Director |
| Raymond Woo | Chief Technology Officer |
| Scott Blumberg | Chief Financial Officer |
| Alex Grant | SVP of Engineering |
| Baharan Kamousi | Senior Vice President of Data Science |
| Brian Price | Senior Vice President of Marketing |
| Dan Rogy | Senior Vice President of Operations |
| David Foehr | Senior Vice President of Finance |
| Josef Parvizi | Co-Founder, Chief Medical Advisor & Director |
| Joseph S. Manni | Chief Revenue Officer |
| Kim McKeon | Vice President of People & Culture |
| Louisa Daniels | General Counsel |
CeriBell
| Country | United States |
| IPO Date | Oct 11, 2024 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 327 |
| CEO | Xingjuan Chao |
Contact Details
360 North Pastoria Avenue Sunnyvale,
California 94085 United States
Stock Details
| Ticker Symbol | CBLL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001861107 |
| CUSIP Number | 15678C102 |
| ISIN Number | US15678C1027 |
| SIC Code | 3845 |
Recent News
- 13 days ago / zacks.comCeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates
- 13 days ago / seekingalpha.comCeriBell, Inc. (CBLL) Q3 2026 Earnings Call Transcript
- 13 days ago / zacks.comCompared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics
- 13 days ago / marketbeat.comCeriBell Q3 Earnings Call Highlights
- 13 days ago / globenewswire.comCeribell Reports Third Quarter 2026 Financial Results
- 15 days ago / globenewswire.comCeribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
- 19 days ago / globenewswire.comCeribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Add to Watchlist
Select watchlists to add or remove CBLL